The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients
NCT00289003
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Oral Mucositis
Interventions
DRUG:
Soluble beta-1,3/1,6-glucan
Sponsor
Biotec Pharmacon ASA